Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma.

Maria SepúlvedaEugenia Martinez-HernandezLydia GabaIvan VictoriaNuria Sola-VallsNeus FalgàsJordi Casanova-MollaFrancesc Graus

Published in: Muscle & nerve (2017)

We report a severe motor polyradiculopathy associated with an anti-PD-1 agent that expands the spectrum of neuromuscular complications of this class of drugs. Muscle Nerve 56: E162-E167, 2017.

Keyphrases

skeletal muscle
risk factors
early onset
advanced non small cell lung cancer
drug induced
epidermal growth factor receptor
smoking cessation